Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ehtisham Mahmud

Interventional Cardiology San Diego, CA Medical Doctor

NPI 1730112335 CMS profile 350290

200 W Arbor Dr, 9434 Medical Center Dr, San Diego, CA 92103

Open in the dashboard

General payments

$108,556

92 records reported · program years 2019–2025

Research payments

$150

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$499,303

2 holdings reported · through program year 2025

Research they led as principal investigator

$1,132,802 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Ehtisham Mahmud of San Diego, CA is reported in the CMS Open Payments database as having received $108,556 across 92 general payments and $150 in research payments paid to them. Separately, studies naming them as principal investigator received $1,132,802 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $499,303 across 2 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,328 13
2024 General $395 4
2023 General $49,871 19
2023 Research $150 2
2022 General $19,476 23
2021 General $19,285 12
2020 General $218 2
2019 General $17,983 19
2025 Ownership $249,999 1
2024 Ownership $249,304 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ehtisham Mahmud
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Ehtisham Mahmud were reported at $1,328. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Ehtisham Mahmud Interventional Cardiology median Middle half National median
2019 $17,983 $1,097 $329–$3,048 $163
2020 $218 $473 $161–$1,480 $114
2021 $19,285 $677 $233–$1,827 $132
2022 $19,476 $978 $333–$2,724 $149
2023 $49,871 $1,136 $382–$2,986 $160
2024 $395 $1,181 $395–$3,326 $164
2025 $1,328 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Siemens Medical Solutions USA, Inc. $38,700 15 payments
  2. Abiomed $27,212 17 payments
  3. Medtronic, Inc. $10,453 16 payments
  4. Philips Electronics North America Corporation $9,824 7 payments
  5. CathWorks, Inc. $9,600 3 payments
  6. Shockwave Medical, Inc $4,102 7 payments
  7. Medtronic Vascular, Inc. $3,000 1 payment
  8. Boston Scientific Corporation $2,546 3 payments
  9. Opsens Inc. $1,375 1 payment
  10. Edwards Lifesciences Corporation $960 11 payments
  11. Other $786 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $44,615 6 payments
  2. Honoraria $22,750 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $22,600 9 payments
  4. Travel and Lodging $14,326 20 payments
  5. Food and Beverage $4,265 54 payments
Products named General payments · program years 2019–2025
  1. Impella $26,955 15 payments
  2. FFRangio $9,600 3 payments
  3. (9547) IGT Systems Undivided $9,505 4 payments
  4. RESOLUTE ONYX $4,411 7 payments
  5. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $3,850 5 payments
  6. Resolute Stents $3,000 1 payment
  7. Resolute Stents $2,700 1 payment
  8. General Therapies $2,400 1 payment
  9. ONYX FRONTIER $1,401 3 payments
  10. SavvyWire $1,375 1 payment
  11. Other $2,032 27 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $150 2 payments

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$121,268

Medicare's payments for the services billed

Medicare patients

196

Average age 75

Services billed

775

76 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 55%
Arthritis 51%
Diabetes 43%
Chronic kidney disease 41%
Atrial fibrillation 39%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

94 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record